Eligible applicants are those working in the field of cancer immunotherapy who want to develop their own immunotherapy clinical trial protocol synopsis (resulting in an approved protocol and consent). This includes, but is not limited to, clinical fellows and junior faculty/attendings with medical, surgical, radiation, urologic, gynecologic, or pediatric oncology training and advanced degree scientists (e.g., Masters, PhD, PharmD, DNP) with research experience and interest in clinical and translational immuno-oncology. Applicants can be from academic, non-profit, or for-profit organizations, including the pharmaceutical industry/biotechnology. Those with other related professional degrees are also encouraged to apply.